Overall Survival (Os) Results Of Randomized Phase Iii Study (Admyre Trial) Of Plitidepsin And Dexamethasone (Dxm) Vs. Dxm Alone In Patients With Relapsed/Refractory Multiple Myeloma (Rrmm): Evaluation Of The Crossover Impact.
JOURNAL OF CLINICAL ONCOLOGY（2018）
Abstract
8018Background: Plitidepsin is a synthetic cyclic depsipeptide isolated from the marine tunicate Aplidium albicans targeting the proto-oncogene eEF1A2, which is over-expressed in multiple myeloma c...
MoreTranslated text
Key words
relapsed/refractory multiple myeloma,multiple myeloma,plitidepsin,dexamethasone,dxm
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined